Filter
272
Filtered Results: 272
Text search:
maladies
cardiovasculaires
Featured
Recommendations
27
New Publications
57
Language
Document type
No document type
114
Guidelines
56
Studies & Reports
53
Strategic & Response Plan
13
Fact sheets
13
Manuals
12
Infographics
5
Training Material
2
Situation Updates
2
Brochures
1
Resource Platforms
1
Countries / Regions
Senegal
20
Benin
15
Global
15
Congo, Democratic Republic of
14
Burkina Faso
12
Haiti
8
Latin America and the Carribbean
8
Cameroon
6
Togo
6
Africa
5
Niger
4
Central African Republic
4
Luxembourg
4
Mali
3
Madagascar
3
East and Southern Africa
3
West and Central Africa
3
Brazil
2
Burundi
2
Colombia
2
Bolivia
2
Middle East and North Africa
2
Western and Central Europe
2
France
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
India
1
Germany
1
Chad
1
Rwanda
1
South Africa
1
Ecuador
1
Bahamas
1
Eastern Europe
1
Djibouti
1
Congo-Brazzaville
1
Canada
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
101
Clinical Guidelines
68
Public Health
27
Women & Child Health
6
Key Resources
5
Capacity Building
2
Pharmacy & Technologies
2
Toolboxes
NCDs
35
COVID-19
34
Mental Health
21
Caregiver
13
Planetary Health
9
Disability
5
HIV
4
TB
4
NTDs
4
Rapid Response
3
Refugee
2
Global Health Education
2
Pharmacy
2
Ebola
1
Conflict
1
Natural Hazards
1
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
The World Heart Federation (WHF) has been advocating globally for stronger
legislation and policy regarding cardiovascular disease (CVD) for many years. Now, as focus shifts from global to national progress, we call on members and colleagues to advocate for greater action on CVD in your local setti...
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Hea...
Development of cardiovascular disease (CVD) is influenced by risk factors such as:
tobacco use, an unhealthy diet, physical inactivity, obesity (which can result from
a combination of unhealthy diet, physical inactivity, and other factors), elevated
blood pressure (hypertension), abnormal blood l...
The American Heart Association and the American College of Cardiology are excited to provide a series of cardiovascular prevention guidelines for the assessment of cardiovascular risk, lifestyle modifications that reduce risk, management of elevated blood cholesterol, and management of increased bod...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
The South African (SA) guidelines for cardiac patients for non-cardiac surgery were developed to address the need for cardiac risk assessment and risk stratification for elective non-cardiac surgical patients in SA, and more broadly in Africa.
The guidelines were developed by updating the Canadian ...
Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi...
This technical package provides a strategic approach to improving cardiovascular health in countries. It comprises six modules and an implementation guide. This package supports Ministries of Health to strengthen CVD management in primary health care settings. The practical, step-by step modules are...
Scientific Brief, 17 June 2021
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
A Manual for Medical Officer
Developed under the Government of India – WHO Collaborative Programme 2008-2009
Accessed: 11.03.2019
This toolkit was developed by the Centers for Disease Control and Prevention (CDC) Division for Heart Disease and Stroke Prevention (DHDSP) to provide healthcare organizations, including those in resource-constrained settings, with the information and resources to implement the HMP and improve hyper...
Durante muchos años, la enfermedad de Chagas ha sido una entidad olvidada en nuestro medio, pese a que Colombia posee las condiciones apropiadas para que esta infección se desarrolle y se perpetúe en el tiempo.
Esto se refleja en el poco conocimiento de la enfermedad y en la existencia de muchos...
Factors to take into account when choosing, reviewing and changing medicines.
Rescue therapy:
For symptomatic hyperglycaemia, consider insulin or a sulfonylurea and review when blood glucose control has been achieved.
Diet and lifestyle advice:
At each point reinforce advice about diet and life...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
Desde el 2016, la Organización Panamericana de la Salud (OPS) ha promovido la implementación de la Iniciativa HEARTS en las Américas, una adaptación regional de la estrategia Global HEARTS de la Organización Mundial de la Salud (OMS). Durante este tiempo, 33 países de la Región de las Améric...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
